###begin article-title 0
###xml 13 17 13 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ApoE</italic>
###xml 17 19 17 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2</italic>
###xml 21 23 21 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E3</italic>
###xml 28 30 28 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E4</italic>
Detection of ApoEE2, E3 and E4 alleles using MALDI-TOF mass spectrometry and the homogeneous mass-extend technology
###end article-title 0
###begin p 1
###xml 606 645 606 645 <email xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">journals.permissions@oxfordjournals.org</email>
The online version of this article has been published under an open access model. Users are entitled to use, reproduce, disseminate, or display the open access version of this article for non-commercial purposes provided that: the original authorship is properly and fully attributed; the Journal and Oxford University Press are attributed as the original place of publication with the correct citation details given; if an article is subsequently reproduced or disseminated not in its entirety but only in part or as a derivative work this must be clearly indicated. For commercial re-use, please contact journals.permissions@oxfordjournals.org
###end p 1
###begin p 2
###xml 288 292 288 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ApoE</italic>
###xml 331 333 331 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2</italic>
###xml 335 337 335 337 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E3</italic>
###xml 342 344 342 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E4</italic>
###xml 346 348 346 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E3</italic>
###xml 402 406 402 406 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ApoE</italic>
###xml 498 502 498 502 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ApoE</italic>
###xml 776 780 776 780 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ApoE</italic>
###xml 1144 1148 1144 1148 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ApoE</italic>
Apolipoprotein (Apo) E is one of the five main types of blood lipoproteins (A-E). It is synthesized primarily in the liver and brain and helps in transporting lipids from one place to another as well as facilitates the clearing of dietary fats, such as triglycerides, from the blood. The ApoE gene exists in three different forms: E2, E3 and E4. E3 is considered to be the normal form. Variants of the ApoE gene have been associated with various diseases. Developing an assay for the genotyping of ApoE variants for use both in clinical and large cohort based association settings would be extremely valuable and would require the use of a platform that has high-throughput capabilities and is highly accurate. Here we describe an assay for the simultaneous genotyping of the ApoE variants in a single bi-plex reaction and a single well using the matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry and the homogeneous mass-extend (hME) technology. The assay is robust, highly accurate and suitable for both clinical applications and for the genotyping of large disease cohorts. Moreover, the prevalence of ApoE variants in a cohort of Caucasians from the central Wisconsin area is outlined.
###end p 2
###begin title 3
INTRODUCTION
###end title 3
###begin p 4
###xml 22 26 22 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ApoE</italic>
###xml 145 146 145 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b1">1</xref>
The apolipoprotein E (ApoE) gene is located on the long (q) arm of chromosome 19 and codes for a protein that exists in several different forms (1). ApoE, which is synthesized primarily in the liver and brain, is one of the five main types of blood lipoproteins (A-E) and is a major component of specific lipoproteins called very low-density lipoproteins. A major function of very low-density lipoproteins is to remove excess cholesterol from the blood and carry it to receptors on the surface of liver cells for processing. ApoE helps in transporting lipids from one place to another and facilitates the clearing of dietary fats, such as triglycerides, from the blood. Maintaining normal levels of cholesterol is essential for the prevention of cardiovascular diseases, including heart attacks and strokes. Defects in the ApoE protein could diminish its ability to bind to the receptors, which leads to an elevated blood cholesterol level.
###end p 4
###begin p 5
###xml 4 8 4 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ApoE</italic>
###xml 47 49 47 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2</italic>
###xml 51 53 51 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E3</italic>
###xml 58 60 58 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E4</italic>
###xml 67 69 67 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E3</italic>
###xml 154 156 154 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E3</italic>
###xml 293 295 293 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2</italic>
###xml 400 402 400 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2</italic>
###xml 403 405 403 405 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2</italic>
###xml 560 561 560 561 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b2">2</xref>
###xml 660 662 660 662 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2</italic>
###xml 664 665 664 665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b3">3</xref>
###xml 732 734 720 722 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2</italic>
###xml 800 801 788 789 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b4">4</xref>
###xml 937 939 925 927 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E4</italic>
###xml 1005 1006 993 994 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b5">5</xref>
###xml 1026 1028 1014 1016 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E4</italic>
###xml 1029 1031 1017 1019 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E4</italic>
###xml 1089 1090 1077 1078 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b5">5</xref>
###xml 632 640 <span type="species:ncbi:9606">patients</span>
###xml 703 711 <span type="species:ncbi:9606">patients</span>
The ApoE gene exists in three different forms, E2, E3 and E4, with E3 being the most common form that is found in more than half the population. The ApoE E3 allele is differentiated by a cysteine at position 112 and an arginine at position 158 in the receptor-binding region of ApoE. The ApoE E2 allele (Cys-112 and Cys-158) has significantly less binding ability. In particular, individuals with an E2/E2 combination may clear dietary fat from their body at a slower rate and are at a higher risk for early vascular disease and type III hyperlipoproteinemia (2). According to a recent study, 94.4% of type III hyperlipoproteinemia patients are homozygous for E2 (3). Inversely, only approximately2% of patients homozygous for ApoE E2 develop the clinical phenotype of hyperlipoproteinemia type III (4). It is, therefore, thought that further genetic or environmental factors must be involved in the development of the disease. The ApoE E4 allele (Arg-112 and Arg-158) has been linked to atherosclerosis (5). Individuals with E4/E4 genotype are at a higher risk of developing the disease (5).
###end p 5
###begin p 6
###xml 5 7 5 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E4</italic>
###xml 148 150 148 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E4</italic>
###xml 171 173 171 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2</italic>
###xml 174 176 174 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E4</italic>
###xml 180 182 180 182 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E3</italic>
###xml 183 185 183 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E4</italic>
###xml 202 204 202 204 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E4</italic>
###xml 206 208 206 208 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E4</italic>
###xml 209 211 209 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E4</italic>
###xml 272 273 272 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b6">6</xref>
###xml 296 298 296 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E4</italic>
###xml 388 392 388 392 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ApoE</italic>
ApoE E4 has also been associated with an increased risk of late onset of Alzheimer's disease (developing after the age of 65). Although one copy of E4 constitutes a risk (E2/E4 or E3/E4), two copies of E4 (E4/E4) indicate a greater risk of developing Alzheimer's disease (6). In itself, the ApoE E4 is neither sufficient nor necessary for the development of Alzheimer's disease. However, ApoE genotyping can increase the specificity of the clinical diagnosis of Alzheimer's disease.
###end p 6
###begin p 7
###xml 48 52 48 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ApoE</italic>
###xml 166 167 166 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b7">7</xref>
###xml 168 169 168 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b9">9</xref>
###xml 730 734 730 734 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ApoE</italic>
###xml 747 749 747 749 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b10">10</xref>
###xml 750 752 750 752 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b14">14</xref>
###xml 1205 1207 1203 1205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b15">15</xref>
###xml 1208 1210 1206 1208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b17">17</xref>
###xml 1372 1377 1370 1375 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 1380 1382 1378 1380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b17">17</xref>
###xml 1577 1582 1575 1580 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 1585 1587 1583 1585 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b18">18</xref>
###xml 1750 1752 1748 1750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b19">19</xref>
###xml 1753 1755 1751 1753 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b24">24</xref>
###xml 1854 1856 1852 1854 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b25">25</xref>
###xml 1857 1859 1855 1857 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b27">27</xref>
Several approaches were used previously to type ApoE alleles. The most commonly used approaches are based on PCR-restriction fragment length polymorphism (PCR-RFLP) (7-9). These approaches, although simple, are not suitable for the high-throughput analysis and alleles are sometimes difficult to be discerned because of the incomplete digestion of the PCR product that is often seen with the use of restriction enzymes. Developing an assay for use in both clinical and large cohort based association settings would be extremely valuable and would require the use of a platform that has high-throughput capabilities and is highly accurate. Mass spectrometry is known for its accuracy and high-throughput potential and was used for ApoE genotyping (10-14); however, the analysis either involved the use of restriction enzymes, expensive Locked Nucleic Acid(R) probes, and/or was not carried out in a single tube. In recent years, matrix-assisted laser desorption/ionization time-of-flight (MADLI-TOF) mass spectrometry combined with the homogeneous mass-extend (hME) reaction has proven very useful for the high-throughput mutation and single nucleotide polymorphism (SNP) analysis in a single tube format (15-17). In a wide scale application of SNP genotyping utilizing 3738 SNPs from the HapMap project using the MALDI-TOF MassARRAY system and the hME technology, Gabriel et al. (17) reported genotyping accuracy of 99.6% at 4-7 plex level of design. This system has also been used as a powerful tool for genetic testing in clinical settings, as recently demonstrated by Buyse et al. (18) by the simultaneous screening of as many as 51 known mutations in the cystic fibrosis gene, in the molecular diagnosis of other genetic and infectious diseases (19-24), and has the potential to become a routine method for both laboratory and clinical applications (25-27).
###end p 7
###begin p 8
###xml 38 42 38 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ApoE</italic>
We describe a novel bi-plex assay for ApoE genotyping based on the MALDI-TOF mass spectrometry and the hME technology, and report the distribution of the ApoE variants in a Caucasian based cohort from central Wisconsin.
###end p 8
###begin title 9
MATERIALS AND METHODS
###end title 9
###begin title 10
DNA samples
###end title 10
###begin p 11
###xml 178 182 <span type="species:ncbi:162683">Mayo</span>
###xml 351 355 <span type="species:ncbi:162683">Mayo</span>
A total of 120 anonymized genomic DNA samples were tested, 41 of which were cross-validated using PCR-RFLP. Seven samples were previously tested and kindly provided to us by the Mayo Clinic reference laboratory. The majority of the samples were of Caucasian ancestry (108 samples), 3 of Asians, 2 of Hispanics and 7 samples were of unknown ethnicity (Mayo Clinic samples).
###end p 11
###begin title 12
Primer design
###end title 12
###begin p 13
###xml 560 568 560 568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Tables 1</xref>
###xml 573 574 573 574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl2">2</xref>
Both the amplification and extension primers were designed using the Assay Designer 2.05-software from Sequenom. This software designs the primers used for amplification and the base extension reactions. It also identifies the appropriate termination mixture to use in the hME reaction. The amplification primers were designed with a 10mer tag sequence to increase their mass so that they would fall outside the range of detection of the MALDI-TOF mass spectrometry. The primers, the expected extended products, and their corresponding masses are presented in Tables 1 and 2.
###end p 13
###begin title 14
PCR for the MALDI-TOF analysis
###end title 14
###begin p 15
###xml 210 211 206 207 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
For the bi-plex PCR amplification, a total of 25 ng of genomic DNA was amplified in a 5 microl reaction mixture containing 0.1 U HotStar Taq enzyme (Qiagen, Valencia, CA), 1x HotStar buffer, 2.5 mM (total) MgCl2, 0.2 mM (each) deoxynucleotide triphosphate, and 150 nM of each of the ApoE112 and ApoE158 forward and reverse primers. The PCR step was initiated with a 95degreesC soak for 15 min, followed by 45 cycles, consisting of 95degreesC for 20 s, 56degreesC for 30 s, 72degreesC for 60 s, and a final extension of 3 min at 72degreesC.
###end p 15
###begin title 16
Shrimp alkaline phosphatase (SAP)
###end title 16
###begin p 17
After PCR, the remaining unincorporated dNTPs were dephosphorylated by adding 2 microl of the SAP cocktail, containing 1.53 microl of water, 0.17 microl of hME reaction buffer (Sequenom) and 0.3 microl of SAP (Sequenom). The 384-well plate was then sealed and placed in a thermal cycler with the following conditions: 37degreesC for 20 min, 85degreesC for 5 min and 4degreesC indefinitely.
###end p 17
###begin title 18
hME reaction, nanodispensing and mass spectrometry
###end title 18
###begin p 19
After the SAP treatment, a 2 microl cocktail, consisting of 1.728 microl water; 0.2 microl hME EXTEND mixture, containing 10x buffer and appropriate d/ddNTPs (Sequenom); 0.54 microl of 10 microM each extension primer mixture and 0.018 microl of 32 U/microl ThermoSequenase (Sequenom) was added. After the hME cocktail addition, the plate was again sealed and placed in a thermal cycler with the following program: 94degreesC for 2 min followed by 55 cycles of 94degreesC for 5 s, 52degreesC for 5 s and 72degreesC for 5 s. The reaction mixture was then desalted by adding 20 microl of a cationic resin mixture (6 mg), SpectroCLEAN (Sequenom). The plate was then sealed and placed in a rotating shaker for 10 min to desalt the hME solution. Completed genotyping reactions were spotted in nanoliter volumes onto a matrix arrayed silicon chip with 384 elements (Sequenom SpectroCHIP) using the MassARRAY Nanodispenser. SpectroCHIPs were analyzed using the Bruker Autoflex MALDI-TOF mass spectrometer and the spectra were processed using the SpectroTYPER software (Sequenom).
###end p 19
###begin title 20
PCR-RFLP
###end title 20
###begin p 21
###xml 120 121 116 117 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 244 251 232 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl2">Table 2</xref>
###xml 943 951 901 909 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1</xref>
A total of 40-50 ng of DNA was amplified in a 25 microl reaction mixture containing a final concentration of 1.5 mM MgCl2, 1x buffer (Qiagen), 200 microM of each dNTP, 0.4 microM of each of the ApoE (F) and YWL-ApoE (R) primers (shaded rows in Table 2), and 0.65 U HotStarTaq DNA polymerase (Qiagen). The PCR was initiated with a 95degreesC soak for 15 min followed by amplification for 35 cycles (94degreesC for 30 s, 65degreesC for 30 s and 72degreesC for 30 s), and a final extension for 10 min at 72degreesC. The YWL-tail attached to the YWL-ApoE primer was added to the primer so that the PCR products, if required to be, can be fluorescently labeled using a fluorescently labeled universal primer that has a primer sequence exactly similar to the tail. Nevertheless, for the validation purposes, the universal primer was never added to the reaction mixture and the PCR product was simply resolved on a regular 3% agarose gel as shown in Figure 1.
###end p 21
###begin p 22
###xml 131 135 127 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ApoE</italic>
###xml 147 151 143 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ApoE</italic>
A volume of 5 microl of the 209 bp PCR product was digested with 2.5 U of AFLIII or 3 U of HaeII enzymes for the genotyping of the ApoE112 and the ApoE158 polymorphisms, respectively, in a 25 microl reaction containing 1x NE buffer 2 and 80 microg/ml BSA. All digestions were incubated at 37degreesC for a minimum of 3 h. The digested PCR product was resolved on a 3% agarose gel (NuSeive 3:1 agarose) containing 5 microl of 10 mg/ml ethidium bromide. The gel was electrophoresed for 55 min at 90 V and visualized under ultraviolet light.
###end p 22
###begin title 23
RESULTS
###end title 23
###begin p 24
###xml 46 54 46 54 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2</xref>
###xml 619 623 619 623 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ApoE</italic>
###xml 631 635 631 635 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ApoE</italic>
###xml 665 673 665 673 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3</xref>
The hME reaction from Sequenom is outlined in Figure 2. Briefly, the assay involves PCR amplification, SAP treatment to remove excess dNTPs, minisequencing using a mixture of dideoxy and deoxy NTPs, cleanup of the extension reaction to remove salt, spotting of the extension product into 384 SpectroCHIPs and the analysis of the spotted product using the MALDI-TOF mass spectrometry. The entire procedure requires only a single tube or well into which reagents are dispensed in successive reaction steps. An example of the spectra obtained from the genotyping of an individual who is compound heterozygous for both the ApoE112 and ApoE158 polymorphisms is shown in Figure 3.
###end p 24
###begin p 25
A total of 120 unique and anonymized DNA samples were tested using the MALDI-TOF mass spectrometry. Scored alleles were assigned a confidence score based on the call (conservative, moderate, aggressive and low probability). More than 99% of the calls had a conservative score and did not require manual checking. Moreover, 57 samples were tested in duplicates in different experiments and the results were always 100% concordant.
###end p 25
###begin p 26
###xml 226 230 226 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ApoE</italic>
###xml 248 252 248 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ApoE</italic>
###xml 358 362 358 362 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ApoE</italic>
###xml 374 375 374 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b7">7</xref>
###xml 376 378 376 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b28">28</xref>
###xml 379 381 379 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b30">30</xref>
###xml 509 510 509 510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b8">8</xref>
###xml 790 791 790 791 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b8">8</xref>
###xml 814 818 814 818 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ApoE</italic>
###xml 912 916 912 916 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ApoE</italic>
###xml 1026 1034 1026 1034 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1</xref>
###xml 98 102 <span type="species:ncbi:162683">Mayo</span>
###xml 1163 1167 <span type="species:ncbi:162683">Mayo</span>
###xml 1261 1265 <span type="species:ncbi:162683">Mayo</span>
For assay validations, out of the 120 samples tested 7 were of known genotypes, provided to us by Mayo Clinic, and 41 samples were genotyped using the PCR-RFLP method using AFLIII and HaeII enzymes, which are specific for the ApoE112 (T/C) and the ApoE158 (C/T) alleles, respectively. Both enzymes were used previously and were validated for the analysis of ApoE genotypes (7,28-30). This method has an advantage over the traditional method utilizing the HhaI enzyme that was developed by Hixson and Vernier (8) in that the product is large enough that it can be visualized in an agarose gel, whereas in the method of Hixson and Vernier the HaeI fragments that are obtained are of very small size that requires to be analyzed by acrylamide gel electrophoresis and the use of radioactivity (8). The AFLIII cuts the ApoE112 'T' allele and results in 185 bp, but does not cut the 'C' allele, whereas HaeII cuts the ApoE158 'C' allele and results in 165 bp, but does not cut the 'T' allele. An example of the PCR-RFLP is shown in Figure 1. The data derived from the MALDI-TOF hME assay were compared with the data derived from the PCR-RFLP assay and the samples from Mayo Clinic. There was 100% concordance between the two assays and with the samples obtained from Mayo Clinic.
###end p 26
###begin p 27
###xml 43 47 43 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ApoE</italic>
###xml 222 224 222 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2</italic>
###xml 226 228 226 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E3</italic>
###xml 233 235 233 235 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E4</italic>
###xml 358 362 358 362 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ApoE</italic>
###xml 405 412 405 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl3">Table 3</xref>
We have also studied the prevalence of the ApoE genotypes in a cohort from central Wisconsin. Of the 216 chromosomes from the 108 Caucasian individuals from central Wisconsin who were typed in this study, the frequency of E2, E3 and E4 was 5.1% (11 chromosomes), 81.5% (176 chromosomes) and 13.4% (29 chromosomes), respectively. The frequency of each of the ApoE genotypes from this study is presented in Table 3.
###end p 27
###begin title 28
DISCUSSION
###end title 28
###begin p 29
###xml 72 76 72 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ApoE</italic>
###xml 443 447 443 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ApoE</italic>
We have developed an efficient assay for the simultaneous genotyping of ApoE variants in a single bi-plex-single well reaction utilizing the MassARRAY system and the hME technology. The MassARRAY system distinguishes molecules based solely on molecular weight. This feature adds so much importance, particularly for genetic testing, because of the extreme high accuracy of the mass spectrometer. In all the testing that was performed with the ApoE assay, we found that this system is extremely accurate and highly reproducible. Moreover, the direct detection of analytes solely based on their molecular weights eliminates the need for labeling or any separation steps. This particular feature when combined with the high multiplexing capability, the wide range of mass detection and the very small reaction volumes makes this system in the long run very cost-effective for high-throughput SNP and mutation analysis. Another important feature of this system is that the actual analytes can be detected directly in real-time, and therefore if a reaction failed, the cause of failure can be easily identified by comparing the size of the peaks of the unextended with the extended primers. Finally, the single tube format, with all the steps needed for PCR amplification, phosphatase treatment, primer extension and desalting of the extension product, performed in the same well without the need for transferring the reaction products for purification outside the well considerably enhances the genotyping throughput and eliminates potential errors associated with the transfer of reaction products.
###end p 29
###begin p 30
###xml 35 37 35 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E4</italic>
###xml 95 97 95 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E4</italic>
###xml 278 280 278 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b31">31</xref>
###xml 354 356 354 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E4</italic>
###xml 725 727 725 727 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b32">32</xref>
###xml 593 605 <span type="species:ncbi:9606">participants</span>
It has been proposed that the ApoE E4 allele may act as a thrifty allele. The exposure of ApoE E4 to the contemporary environmental conditions (western diet and longer lifespan) could have rendered it a susceptibility allele for coronary artery disease and Alzheimer's disease (31). We identified the frequency of the ApoE alleles, and specifically ApoE E4 allele, in a cohort from central Wisconsin. A recent self-reported ethnic origin survey on a large cohort from Marshfield Clinic Personalized Medicine research program, one of the largest DNA biobanks in the world with more than 18 000 participants from central and northern Wisconsin, has found that 76.7% of all Caucasians in central Wisconsin are of German origin (32).
###end p 30
###begin p 31
###xml 177 182 177 182 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 185 187 185 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b33">33</xref>
###xml 238 240 238 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2</italic>
###xml 242 244 242 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E3</italic>
###xml 249 251 249 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E4</italic>
###xml 417 419 417 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2</italic>
###xml 421 423 421 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E3</italic>
###xml 428 430 428 430 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E4</italic>
###xml 473 474 473 474 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 531 533 531 533 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2</italic>
###xml 617 619 617 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b31">31</xref>
Two separate large cohort studies reported frequencies of the ApoE alleles in Caucasians from the US and Europe. Using a cohort of US Caucasians of non-Hispanic origin, Mastana et al. (33) reported allele frequencies of 8, 78 and 14% for E2, E3 and E4, respectively. Recently, a more relevant larger study that investigated ApoE allele distribution in the world, including Germany, reported a 7.7, 77.8 and 14.5% for E2, E3 and E4, respectively, for the German population (n = 2031). This particular study also found that the ApoE E2 frequency fluctuates with no apparent trend ranging from 2% to 14.5% in the world (31).
###end p 31
###begin p 32
###xml 49 50 49 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 204 205 204 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Despite the relatively small size of our cohort (n = 108), we observed an overall allele distribution similar to previous studies, with no significant difference in allele distribution (Chi-squared test, P > 0.56).
###end p 32
###begin p 33
###xml 69 73 69 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ApoE</italic>
In summary, we have developed a highly accurate genotyping assay for ApoE 112 and 158 polymorphisms using the MALDI-TOF mass spectromtry and the hME technology that is suitable for both clinical and large-scale research applications.
###end p 33
###begin p 34
###xml 36 40 <span type="species:ncbi:162683">Mayo</span>
The authors would like to thank the Mayo Clinic's Molecular Genetics Laboratory for providing DNA samples for assay validations and Marshfield Clinic Research Foundation for its support through the services of Linda Weis and Alice Stargardt in the preparation of this manuscript. Funding to pay the Open Access publication charges for this article was provided by Marshfield Clinic Research Foundation.
###end p 34
###begin p 35
###xml 0 30 0 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Conflict of interest statement</italic>
Conflict of interest statement. None declared.
###end p 35
###begin title 36
REFERENCES
###end title 36
###begin article-title 37
Apolipoprotein E: cholesterol transport protein with expanding role in cell biology
###end article-title 37
###begin article-title 38
Studies of familial type III hyperlipoproteinemia using as a genetic marker the apoE phenotype E2/2
###end article-title 38
###begin article-title 39
Molecular basis of type III hyperlipoproteinemia in Germany
###end article-title 39
###begin article-title 40
###xml 18 26 <span type="species:ncbi:9606">patients</span>
Apo E variants in patients with type III hyperlipoproteinemia
###end article-title 40
###begin article-title 41
Apolipoprotein E polymorphism and atherosclerosis
###end article-title 41
###begin article-title 42
Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families
###end article-title 42
###begin article-title 43
A simple and efficient method for apolipoprotein E genotype determination
###end article-title 43
###begin article-title 44
###xml 25 30 <span type="species:ncbi:9606">human</span>
Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI
###end article-title 44
###begin article-title 45
Optimization of apolipoprotein E genotyping
###end article-title 45
###begin article-title 46
Identification of apolipoprotein E polymorphisms using temperature cycled primer oligo base extension and mass spectrometry
###end article-title 46
###begin article-title 47
Genotyping of apolipoprotein E by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry
###end article-title 47
###begin article-title 48
PNA for one-base differentiating protection of DNA from nuclease and its use for SNPs detection
###end article-title 48
###begin article-title 49
Straightforward detection of SNPs in double-stranded DNA by using exonuclease III/nuclease S1/PNA system
###end article-title 49
###begin article-title 50
LNA-enhanced detection of single nucleotide polymorphisms in the apolipoprotein E
###end article-title 50
###begin article-title 51
Automated genotyping using the DNA MassArray technology
###end article-title 51
###begin article-title 52
High-throughput multiplex SNP genotyping with MALDI-TOF mass spectrometry: practice, problems and promise
###end article-title 52
###begin article-title 53
###xml 41 46 <span type="species:ncbi:9606">human</span>
The structure of haplotype blocks in the human genome
###end article-title 53
###begin article-title 54
Use of MALDI-TOF mass spectrometry in a 51-mutation test for cystic fibrosis: evidence that 3199del6 is a disease-causing mutation
###end article-title 54
###begin article-title 55
A matrix-assisted laser desorption/ionization time-of-flight based method for screening the 1691G(A mutation in the factor V gene
###end article-title 55
###begin article-title 56
Genotyping of thrombotic risk factors by MALDI-TOF mass spectrometry
###end article-title 56
###begin article-title 57
Molecular diagnosis of familial adenomatous polyposis (FAP): genotyping of adenomatous polyposis coli (APC) alleles by MALDI-TOF mass spectrometry
###end article-title 57
###begin article-title 58
High-level multiplex genotyping of polymorphisms involved in folate or homocysteine metabolism by matrix-assisted laser desorption/ionization mass spectrometry
###end article-title 58
###begin article-title 59
Four common mutations of the cystathionine beta-synthase gene detected by multiplex PCR and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry
###end article-title 59
###begin article-title 60
###xml 83 100 <span type="species:ncbi:11103">hepatitis C virus</span>
Matrix-assisted laser desorption ionization-time of flight (mass spectrometry) for hepatitis C virus genotyping
###end article-title 60
###begin article-title 61
Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry in clinical chemistry
###end article-title 61
###begin article-title 62
High throughput screening of genetic polymorphisms by matrix-assisted laser desorption ionization time-of-flight mass spectrometry
###end article-title 62
###begin article-title 63
Genotyping single nucleotide polymorphisms by MALDI mass spectrometry in clinical applications
###end article-title 63
###begin article-title 64
Apolipoprotein E1 Baden (Arg(180)-->Cys). A new apolipoprotein E variant associated with hypertriglyceridemia
###end article-title 64
###begin article-title 65
Is a polymorphism of the apolipoprotein E gene associated with preeclampsia
###end article-title 65
###begin article-title 66
Improved method for genotyping apolipoprotein E polymorphisms by a PCR-based assay simultaneously utilizing two distinct restriction enzymes
###end article-title 66
###begin article-title 67
Apolipoprotein E (APOE) allele distribution in the world. Is APOE?4 a 'thrifty' allele
###end article-title 67
###begin article-title 68
Marshfield Clinic Personalized Medicine Research Project (PMRP): design, methods and recruitment for a large population-based biobank
###end article-title 68
###begin article-title 69
###xml 39 44 39 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">apo E</italic>
Anthropology of the apoplipoprotein E (apo E) gene: low frequency of apo E4 allele in Basques and in tribal (Baiga) populations of India
###end article-title 69
###begin title 70
Figures and Tables
###end title 70
###begin p 71
###xml 14 18 14 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ApoE</italic>
###xml 335 339 335 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ApoE</italic>
###xml 422 426 422 426 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ApoE</italic>
###xml 556 558 556 558 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E4</italic>
###xml 645 650 645 650 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E3/E3</italic>
###xml 741 746 741 746 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2/E3</italic>
Validation of ApoE variants using PCR-RFLP. PCR products from representative samples were analyzed on a 3% agarose gel. From left to right, lane 1 is the 1 kb ladder size, standard; lanes 2-4, H0001; lanes 5-7, H0003; and lanes 8-10, H0007. Uncut PCR products are loaded in lanes 2, 5 and 8. AFLIII digestion products specific for the ApoE112 site are loaded in lanes 3, 6 and 9. HaeII digestion products specific for the ApoE158 site are loaded in lanes 4, 7 and 10. H0001 is (T/C) at position 112 and (C/C) at position 158, resulting in a genotype of E3/E4; H0003 is (T/T) at position 112 and (C/C) at position 158, resulting in a genotype of E3/E3; and H0007 is (T/T) at position 112 and (C/T) at position 158, resulting in a genotype of E2/E3.
###end p 71
###begin p 72
Outline of the homogeneous mass-extend (hME) technology. The ApoE detection involves the amplification and detection of the two variants, simultaneously. For simplicity, only one variant is illustrated in this diagram.
###end p 72
###begin p 73
###xml 47 51 47 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ApoE</italic>
###xml 59 63 59 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ApoE</italic>
###xml 178 179 178 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">x</italic>
###xml 232 233 232 233 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">y</italic>
###xml 276 280 276 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ApoE</italic>
###xml 327 331 327 331 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ApoE</italic>
Simultaneous detection of the hME products for ApoE112 and ApoE158 variants using MALDI-TOF mass spectrometry. An example of the MALDI-TOF detection is shown in this figure. The x-axis shows the mass of the analytes in Daltons, the y-axis shows the intensity of the peak. The ApoE112 calls are shown in open boxes, whereas the ApoE158 are shown in solid boxes. The positions of pausing peaks that may result from incomplete extension of the extending primer are shown by dotted lines and are distinguishable from the fully extended product. For this assay we have not seen any detectable pausing peaks. The genotype call is shown in the upper right of the figure.
###end p 73
###begin p 74
ApoE extension primers and products, with their calculated masses
###end p 74
###begin p 75
The extended products are underlined. 'UE' denotes 'unextended.'
###end p 75
###begin p 76
###xml 25 29 25 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ApoE</italic>
###xml 37 41 37 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ApoE</italic>
Primers encompassing the ApoE112 and ApoE158 variants
###end p 76
###begin p 77
The 10mer tag sequence is italicized and underlined. The shaded primers were used for the PCR-RFLP analysis. The YWL-tail sequence is in boldface and underlined.
###end p 77
###begin p 78
###xml 27 31 27 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ApoE</italic>
Genotypes and frequency of ApoE variants
###end p 78

